Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice

Cancer Cell
Justyna T RomerTom Curran

Abstract

Medulloblastoma is the most common malignant pediatric brain tumor. Current treatment is associated with major long-term side effects; therefore, new nontoxic therapies, targeting specific molecular defects in this cancer, need to be developed. We use a mouse model of medulloblastoma to show that inhibition of the Sonic Hedgehog (Shh) pathway provides a novel therapy for medulloblastoma. A small molecule inhibitor of the Shh pathway, HhAntag, blocked the function of Smoothened in mice with medulloblastoma. This resulted in suppression of several genes highly expressed in medulloblastoma, inhibition of cell proliferation, increase in cell death and, at the highest dose, complete eradication of tumors. Long-term treatment with HhAntag prolonged medulloblastoma-free survival. These findings support the development of Shh antagonists for the treatment of medulloblastoma.

References

Apr 1, 1980·The Journal of Allergy and Clinical Immunology·S R Hirsch, J H Kalbfleisch
Feb 1, 1995·Journal of Pediatric Hematology/oncology·A ZvulunovN B Esterly
Jan 12, 1999·Neuron·L V Goodrich, M P Scott
Mar 30, 2000·Genes, Chromosomes & Cancer·R H ZurawelC Raffel
Apr 3, 2001·Annual Review of Neuroscience·R Wechsler-Reya, M P Scott
Apr 18, 2001·Current Opinion in Oncology·M ChintagumpalaS M Blaney
Nov 23, 2001·Journal of Neuro-oncology·R B Corcoran, M P Scott
Feb 8, 2002·Cell·Terry Van Dyke, Tyler Jacks
Jun 18, 2002·Nature Genetics·Michael D TaylorDavid Hogg
Aug 15, 2002·Neuropathology and Applied Neurobiology·D Ellison
Aug 31, 2002·Science·David M BermanPhilip A Beachy
Nov 5, 2002·Genes & Development·James K ChenPhilip A Beachy
Apr 8, 2003·Proceedings of the National Academy of Sciences of the United States of America·Juliet A WilliamsFrank Y Wang
Apr 17, 2003·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·David W EllisonRichard J Gilbertson
Aug 29, 2003·Neurosurgery·Göran Hesselager, Eric C Holland
Oct 2, 2003·Nature·Sarah P ThayerMatthias Hebrok
Nov 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Tsuyoshi AkagiHidesaburo Hanafusa
Feb 19, 2004·Brain Research. Molecular Brain Research·Adrian J FrankRichard J Gilbertson

❮ Previous
Next ❯

Citations

Aug 20, 2010·EMBO Molecular Medicine·Tom Curran
Jan 11, 2005·The Journal of Pathology·Scott K Lyons
Feb 9, 2012·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Jasmine LauWilliam A Weiss
Jun 13, 2008·Neurosurgical Review·Carlos G CarlottiJames T Rutka
Mar 1, 2012·Journal of the Association for Research in Otolaryngology : JARO·Joanna Mulvaney, Alain Dabdoub
Feb 21, 2009·Apoptosis : an International Journal on Programmed Cell Death·Nikhil S ChariTimothy J McDonnell
Jun 20, 2008·Breast Cancer Research and Treatment·Xiaomei ZhangMichael T Lewis
Apr 26, 2006·Current Neurology and Neuroscience Reports·Timothy R Gershon, Orren J Becher
Oct 17, 2006·Current Oncology Reports·Nicole J Ullrich, Scott L Pomeroy
Jun 4, 2008·Current Urology Reports·Chad M Vezina, And Wade Bushman
Sep 1, 2006·Current Treatment Options in Neurology·Nicholas G Gottardo, Amar Gajjar
Sep 4, 2012·Archives of Pharmacal Research·Jeong In YunJongkook Lee
Feb 19, 2009·The Cerebellum·Catherine Vaillant, Denis Monard
Jun 1, 2005·Cancer Letters·Simonetta Pazzaglia
Jun 30, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Sabine Mueller, Susan Chang
Dec 3, 2004·Drug Discovery Today·Jane Bradbury
Jan 25, 2012·Journal of Medicinal Chemistry·Antonio SolinasMartial Ruat
Mar 25, 2009·Journal of Medicinal Chemistry·Neeraj MahindrooNaoaki Fujii
Jan 5, 2012·Molecular Pharmaceutics·Ryan R HurtadoThomas J Meade
Nov 19, 2004·Nature·Charles Sawyers
Dec 15, 2010·Nature·Paul GibsonRichard J Gilbertson
Nov 17, 2009·Nature Medicine·Alvin C LinBenjamin A Alman
May 27, 2005·Nature Neuroscience·Anna Marie Kenney, Rosalind A Segal
Feb 3, 2005·Nature Reviews. Cancer·Michael A Dyer, Rod Bremner
Sep 4, 2010·Nature Reviews. Cancer·John P MorrisMatthias Hebrok
May 27, 2011·Nature Reviews. Cancer·Jessica M Y Ng, Tom Curran
Dec 2, 2006·Nature Reviews. Drug Discovery·Lee L Rubin, Frederic J de Sauvage
Oct 2, 2009·Nature Reviews. Drug Discovery·Bin-Bing S ZhouPeter B Dirks
Jun 10, 2006·Cell Death and Differentiation·K B SpurgersT J McDonnell
Apr 5, 2005·Oncogene·Hiromichi KimuraTom Curran
Apr 25, 2007·Oncogene·Y LeeP J McKinnon
Sep 4, 2009·The New England Journal of Medicine·Charles M RudinJennifer A Low
Feb 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Yu WangAndrew P McMahon
May 3, 2012·Proceedings of the National Academy of Sciences of the United States of America·Michelle J LeeJames M Olson
Apr 16, 2009·The Journal of Biological Chemistry·Hongbo YangShuo Lin
Apr 24, 2008·Stem Cells and Development·Anand VeeravaguVictor Tse
Feb 25, 2009·Carcinogenesis·Maria KasperRune Toftgård
Dec 7, 2013·Neuro-oncology·Tobey J MacDonaldRobert C Castellino
Mar 19, 2008·Genes & Development·Kimberly J BriggsD Neil Watkins

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Carcinoma, Basal Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.